Evidence map›Paper›PMID 34734354›Full record

ReviewBiotechnology letters2022

Superoxide dismutase as multipotent therapeutic antioxidant enzyme: Role in human diseases.

Priyanka Saxena, Kanagarethinam Selvaraj, Sunil Kumar Khare, Nidhee Chaudhary

Abstract readReview
PubMed Publisher
In one paragraph

Review in Biotechnology letters, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
8.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 137 citations in OpenAlex.

  1. Review
  2. Nutrients · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Is Ferroptosis and Oxidative Stress Involved in NSTEMI Patient's?Research in heart yield and translational medicine · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Pharmacological Characterization ofRecent advances in inflammation & allergy drug discovery · 2026
    Article
  20. Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Priyanka SaxenaCentre for Biotechnology and Biochemical Engineering, Amity Institute of Biotechnology, Amity University Uttar Pradesh, Noida, Uttar Pradesh, 201313, India.
Kanagarethinam SelvarajCentre for Biotechnology and Biochemical Engineering, Amity Institute of Biotechnology, Amity University Uttar Pradesh, Noida, Uttar Pradesh, 201313, India.
Sunil Kumar KhareR&D & Institute Chair Professor of Biochemistry, Enzyme and Microbial Biochemistry Lab, Department of Chemistry, Indian Institute of Technology Delhi, New Delhi, 110016, India.
Nidhee ChaudharyCentre for Biotechnology and Biochemical Engineering, Amity Institute of Biotechnology, Amity University Uttar Pradesh, Noida, Uttar Pradesh, 201313, India. nchaudhary@amity.edu.ORCID http://orcid.org/0000-0002-1295-3330
Amity University · INIndian Institute of Technology Delhi · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reactive oxygen species (ROS) is consistently recognized as a threat to living organisms, especially for human beings. For proper working of cellular signaling, functioning, and survival, a strict and balanced level of ROS is necessary. Superoxide dismutase (SOD); a group of metalloenzymes provides an important antioxidant defense mechanism, required to preserve the level of ROS in the body. The enzyme reveals the therapeutic potential against various diseases due to a deficiency in the ROS level. The review illustrates the numerous clinical aspects of SOD in various physiological and pathological conditions such as cancer, diabetes, arthritis, cardiovascular, neurodegenerative diseases, etc., with the mechanism of action. Despite limitations, the SOD enzyme has proved as a powerful tool against diseases, and various forms of conjugates and mimetics have been developed and reported to make it more efficient. Extensive studies need in this direction for use of natural SOD-based therapeutics for the prevention and cure of diseases.

Indexed as

NeoplasmsNeurodegenerative DiseasesAntioxidantsHumansReactive Oxygen SpeciesSuperoxide DismutaseAntioxidantsReactive Oxygen SpeciesSuperoxide DismutaseMetalloenzymePathophysiological conditionsReactive oxygen speciesSOD-based therapeutics

Identifiers

PMID34734354
OpenAlexW3210446559

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.